Kawasaki disease

BMJ. 2014 Sep 17:349:g5336. doi: 10.1136/bmj.g5336.

Authors

Anthony Harnden¹, Robert Tulloh², David Burgner³

Affiliations

¹ Department of Primary Care Health Sciences, University of Oxford, Oxford, UK anthony.harnden@phc.ox.ac.uk.
² University Hospitals Bristol NHS Foundation Trust, University of Bristol, Bristol, UK.
³ Murdoch Childrens Research Institute and Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.

PMID: 25230954
DOI: 10.1136/bmj.g5336

No abstract available

Publication types

Case Reports
Review

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Aspirin / therapeutic use
Child, Preschool
Humans
Immunoglobulins, Intravenous / therapeutic use
Immunologic Factors / therapeutic use
Male
Mucocutaneous Lymph Node Syndrome / complications
Mucocutaneous Lymph Node Syndrome / diagnosis*
Mucocutaneous Lymph Node Syndrome / drug therapy*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Immunoglobulins, Intravenous
Immunologic Factors
Aspirin